Gritstone bio, Inc.

OTCPK:GRTS.Q Stock Report

Market Cap: US$3.5m

Gritstone bio Management

Management criteria checks 2/4

Gritstone bio's CEO is Andrew Allen, appointed in Aug 2015, has a tenure of 9.25 years. total yearly compensation is $3.44M, comprised of 18.8% salary and 81.2% bonuses, including company stock and options. directly owns 1.53% of the company’s shares, worth $54.35K. The average tenure of the management team and the board of directors is 3.7 years and 6.5 years respectively.

Key information

Andrew Allen

Chief executive officer

US$3.4m

Total compensation

CEO salary percentage18.8%
CEO tenure9.3yrs
CEO ownership1.5%
Management average tenure3.7yrs
Board average tenure6.5yrs

Recent management updates

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Recent updates

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering

Apr 07

Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Aug 14
Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst

Sep 26

Gritstone reaches six-month high on publication of data for cancer vaccine

Aug 16

Gritstone bio announces $80M credit facility

Jul 21

Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Jul 07
Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Gritstone bio: Potential To Advance Colorectal Cancer Treatment

Jul 05

Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation

Jun 14

Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

Mar 17
Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Mar 05
We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Gritstone: Why The Stock Fell On Positive Data

Jan 18

CEO Compensation Analysis

How has Andrew Allen's remuneration changed compared to Gritstone bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$133m

Mar 31 2024n/an/a

-US$145m

Dec 31 2023US$3mUS$646k

-US$138m

Sep 30 2023n/an/a

-US$139m

Jun 30 2023n/an/a

-US$130m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$620k

-US$120m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$116m

Mar 31 2022n/an/a

-US$112m

Dec 31 2021US$4mUS$589k

-US$75m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$2mUS$569k

-US$105m

Sep 30 2020n/an/a

-US$106m

Jun 30 2020n/an/a

-US$107m

Mar 31 2020n/an/a

-US$103m

Dec 31 2019US$2mUS$533k

-US$94m

Sep 30 2019n/an/a

-US$84m

Jun 30 2019n/an/a

-US$75m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$2mUS$475k

-US$65m

Sep 30 2018n/an/a

-US$65m

Jun 30 2018n/an/a

-US$56m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$592kUS$436k

-US$41m

Compensation vs Market: Andrew's total compensation ($USD3.44M) is above average for companies of similar size in the US market ($USD647.72K).

Compensation vs Earnings: Andrew's compensation has increased whilst the company is unprofitable.

CEO

Andrew Allen (58 yo)

9.3yrs

Tenure

US$3,444,071

Compensation

Dr. Andrew R. Allen, BM, BCh, MA, MRCP, M.D., Ph D., serves as Independent Director at Verge Analytics, Inc. since September 2021. He has also held clinical development leadership positions at Chiron Corpo...

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Allen
Co-Founder9.3yrsUS$3.44m1.53%
$ 54.3k
Erin Jones
Executive VP & COO3.7yrsUS$1.52m0.063%
$ 2.2k
Karin Jooss
Executive VP and Head of Research & Development3.7yrsUS$1.58m0.39%
$ 13.8k
Vassiliki Economides
Executive VP & CFO3.4yrsno data0.059%
$ 2.1k
James Cho
Chief Accounting Officer3.8yrsno data0.070%
$ 2.5k
George MacDougall
Director of Investor Relations & Corporate Communicationsno datano datano data
Stacy Proctor
Executive VP & Chief People Officer3.3yrsno datano data
Matthew Hawryluk
Executive VP & Chief Business Officer9yrsno data0.034%
$ 1.2k

3.7yrs

Average Tenure

52yo

Average Age

Experienced Management: GRTS.Q's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Allen
Co-Founder9.3yrsUS$3.44m1.53%
$ 54.3k
Elaine Jones
Independent Chairman of the Board5.2yrsUS$176.00k0%
$ 0
Stephen Webster
Independent Directorless than a yearno data0.021%
$ 750.1
Lawrence Corey
Independent Director2.3yrsUS$132.50k0%
$ 0
Timothy Chan
Member of Scientific Advisory Board7.4yrsno datano data
Eugene Zhukovsky
Member of Scientific Advisory Board5.6yrsno data0%
$ 0
Graham Lord
Member of Scientific Advisory Board7.4yrsno datano data
Naiyer Rizvi
Independent Director & Member of Scientific Advisory Board8.4yrsUS$140.00k0%
$ 0
James Gulley
Member of Scientific Advisory Board7.4yrsno datano data
Alessandro Sette
Member of Scientific Advisory Board7.4yrsno datano data
Shefali Agarwal
Independent Director3.4yrsUS$138.50k0%
$ 0
Clare Fisher
Independent Director2.8yrsUS$136.50kno data

6.5yrs

Average Tenure

61.5yo

Average Age

Experienced Board: GRTS.Q's board of directors are considered experienced (6.5 years average tenure).